161 related articles for article (PubMed ID: 8849768)
1. Role of screening in reducing invasive cervical cancer registrations in England.
Fouquet R; Gage H
J Med Screen; 1996; 3(2):90-6. PubMed ID: 8849768
[TBL] [Abstract][Full Text] [Related]
2. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.
Macgregor JE; Campbell MK; Mann EM; Swanson KY
BMJ; 1994 May; 308(6941):1407-11. PubMed ID: 8019250
[TBL] [Abstract][Full Text] [Related]
3. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
4. The use of screening episodes linked to CIN3 and invasive cancer registrations to study outcomes from the NHS Cervical Screening Programme.
Blanks RG; Moss SM; Coleman DA; Addou S; Swerdlow AJ
Cytopathology; 2009 Jun; 20(3):154-60. PubMed ID: 19207309
[TBL] [Abstract][Full Text] [Related]
5. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.
Deerasamee S; Srivatanakul P; Sriplung H; Nilvachararung S; Tansuwan U; Pitakpraiwan P; Kaewkungwal J; Singhasivanon P; Nimnakorn P; Sankaranarayanan R
Asian Pac J Cancer Prev; 2007; 8(4):547-56. PubMed ID: 18260727
[TBL] [Abstract][Full Text] [Related]
6. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
7. Cervical neoplasia in pap smears: risk of cervical intra-epithelial neoplasia (CIN) after negative or no prior smears in a population without a mass screening programme.
Forsmo S; Jacobsen BK; Stalsberg H
Int J Epidemiol; 1996 Feb; 25(1):53-8. PubMed ID: 8666505
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
Gram IT; Macaluso M; Stalsberg H
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
[TBL] [Abstract][Full Text] [Related]
9. Towards achieving the Health of the Nation target for cervical cancer: accuracy of cancer registration.
Lancaster G; Moran T; Woodman C
J Public Health Med; 1994 Mar; 16(1):50-2. PubMed ID: 8037953
[TBL] [Abstract][Full Text] [Related]
10. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
11. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
12. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme.
Nygård JF; Sauer T; Nygård M; Skare GB; Thoresen SØ
J Med Screen; 2004; 11(2):70-6. PubMed ID: 15153321
[TBL] [Abstract][Full Text] [Related]
13. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
[TBL] [Abstract][Full Text] [Related]
14. Dramatic increase in cervical cancer registrations in young women in 2009 in England unlikely to be due to the new policy not to screen women aged 20-24.
Sasieni P; Castanon A
J Med Screen; 2012 Sep; 19(3):127-32. PubMed ID: 23093730
[TBL] [Abstract][Full Text] [Related]
15. Risk of cervical cancer after a negative Pap smear.
Viikki M; Pukkala E; Hakama M
J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
[TBL] [Abstract][Full Text] [Related]
16. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
17. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
[TBL] [Abstract][Full Text] [Related]
18. [Cervical cancer screening in Poland and worldwide].
Spaczyński M; Nowak-Markwitz E; Kedzia W
Ginekol Pol; 2007 May; 78(5):354-60. PubMed ID: 17867325
[TBL] [Abstract][Full Text] [Related]
19. CIN 2/3 and cervical cancer after an ASCUS pap smear. A 7-year, prospective study of the Norwegian population-based, coordinated screening program.
Nygård JF; Sauer T; Skjeldestad FE; Skare GB; Thoresen SØ
Acta Cytol; 2003; 47(6):991-1000. PubMed ID: 14674068
[TBL] [Abstract][Full Text] [Related]
20. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia.
Nygård JF; Nygård M; Skare GB; Thoresen SO
Acta Cytol; 2006; 50(3):295-302. PubMed ID: 16780024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]